Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7551
Lifecore Biomedical
LFCR
$176M
| $638K | ﹤0.01% |
+58,795
| New | +$607K |
|
7552
Myriad Genetics
MYGN
$311M
| $638K | ﹤0.01% |
32,258
-5,573
| -15% | -$90K |
|
7553
CALL
Ocular Therapeutix
OCUL
$2.03B
| $638K | ﹤0.01% |
30,800
+5,700
| +23% | +$84.7K |
|
7554
PUT
Prestige Consumer Healthcare
PBH
$2.51B
| $638K | ﹤0.01% |
+18,300
| New | +$650K |
|
7555
T. Rowe Price
TROW
$24.3B
| $638K | ﹤0.01% |
4,213
-180,612
| -98% | -$25.8M |
|
7556
Capital City Bank Group
CCBG
$881M
| $637K | ﹤0.01% |
25,918
-853
| -3% | -$19.6K |
|
7557
ProShares UltraShort Energy
DUG
$19.1M
| $637K | ﹤0.01% |
+1,104
| New | +$922K |
|
7558
PUT
IDEX
IEX
$17.2B
| $637K | ﹤0.01% |
3,200
-4,900
| -60% | -$932K |
|
7559
Quanex
NX
$969M
| $637K | ﹤0.01% |
28,734
-3,203
| -10% | -$65.9K |
|
7560
Old Second Bancorp
OSBC
$1.29B
| $637K | ﹤0.01% |
63,023
-7,993
| -11% | -$75.9K |
|
7561
Cedar Fair
FUN
$1.62B
| $636K | ﹤0.01% |
+16,177
| New | +$538K |
|
7562
Hooker Furnishings Corp
HOFT
$158M
| $636K | ﹤0.01% |
19,726
+667
| +3% | +$20.2K |
|
7563
Virtus Reaves Utilities ETF
UTES
$1.28B
| $636K | ﹤0.01% |
15,823
-19,035
| -55% | -$765K |
|
|
BFX
7564
DELISTED
BowFlex Inc.
BFX
| $636K | ﹤0.01% |
35,060
-101,050
| -74% | -$2.1M |
|
|
OSH
7565
PUT
DELISTED
Oak Street Health, Inc.
OSH
| $636K | ﹤0.01% |
+10,400
| New | +$546K |
|
7566
Virtus Biotech Clinical Trials ETF
BBC
$49.7M
| $635K | ﹤0.01% |
12,801
+2,083
| +19% | +$93.6K |
|
7567
Teucrium Corn Fund
CORN
$165M
| $635K | ﹤0.01% |
40,737
-117,983
| -74% | -$1.65M |
|
|
SILV
7568
CALL
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $635K | ﹤0.01% |
56,800
+33,300
| +142% | +$313K |
|
7569
Hess Midstream
HESM
$5.21B
| $634K | ﹤0.01% |
32,377
+4,141
| +15% | +$75K |
|
|
IDLB
7570
DELISTED
Invesco FTSE International Low Beta Equal Weight ETF
IDLB
| $634K | ﹤0.01% |
21,346
-1,199
| -5% | -$33.9K |
|
|
VIVO
7571
CALL
DELISTED
Meridian Bioscience Inc
VIVO
| $634K | ﹤0.01% |
33,900
+13,300
| +65% | +$248K |
|
|
ALE
7572
DELISTED
Allete
ALE
| $633K | ﹤0.01% |
10,220
-19,768
| -66% | -$1.12M |
|
7573
Resideo Technologies
REZI
$3.67B
| $633K | ﹤0.01% |
29,782
-9,858
| -25% | -$158K |
|
7574
Spero Therapeutics
SPRO
$71.8M
| $633K | ﹤0.01% |
32,638
+11,328
| +53% | +$177K |
|
7575
TriNet
TNET
$3.09B
| $633K | ﹤0.01% |
7,858
-1,018
| -11% | -$75.3K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.